July 10, 2025

A Powerful Team Researches Re-irradiation Options for Breast Cancer Recurrence

When breast cancer returns in a previously treated breast, the standard approach has been salvage mastectomy. The recently launched BRASIL trial (NCT06867484) aims to challenge this paradigm by investigating whether carefully selected patients can safely undergo repeat breast conservation with partial re-irradiation.

Baptist Health South Florida

June 27, 2025

Botulinum Toxin and Scopolamine for Radiation-Induced Salivary Gland Toxicity in Metastatic Prostate Cancer

Injection with botulinum toxin type A plus transdermal scopolamine led to the reduction in radiation-induced salivary gland toxicity without compromising PSMA tumor uptake in patients with metastatic ...

The ASCO Post

June 26, 2025

GPC3-Targeted ImmunoPET Helps Detect Earlier-Stage Hepatocellular Carcinoma

A novel immunoPET imaging agent targeting GPC3 demonstrated high sensitivity and specificity in detecting GPC3-positive hepatocellular carcinoma (HCC) tumors, according to the results of a pilot clini...

The ASCO Post

May 06, 2025

Mammograms: The Experts Share Their Thoughts

In 2025, approximately 375,000 cases of breast cancer are expected to be diagnosed in the U.S., according to the American Cancer Society.

Baptist Health South Florida

March 12, 2025

As Technology Progresses, Aneurysm Treatments Become Safer and More Reasonable to Consider

Observing the 2.4 mm aneurysm in one female patient seemed reasonable in 2013. But when the evolution of endovascular techniques and technology provided an opportunity to cure her aneurysm in 2024, the 70-year-old patient sought treatment at Mount Sinai’s Cerebrovascular Center. By then, imaging had revealed the aneurysm to be nearly 7 mm in size.

Mount Sinai New York

June 13, 2025

Weight Loss Drugs Show Promise for Heart Failure

ACC statement highlights semaglutide and tirzepatide as therapies associated with improved symptoms and functional capacity in patients with heart failure with preserved ejection fraction and obesity.

Conexiant

December 04, 2024

Can NST-628 Fill the Treatment Void For Advanced Tumors with RAS or RAF Mutations?

A phase 1 clinical trial underway at Roswell Park Comprehensive Cancer Center will evaluate the potential of a “molecular glue” to treat MAPK pathway-mutated advanced solid tumors in patients who have exhausted standard treatment options.

Roswell Park Comprehensive Cancer Center

June 18, 2024

New Guidelines for Radiation Therapy for HPV-associated Head and Neck Cancer

Radiation therapy for HPV-positive oropharyngeal squamous cell carcinoma: An ASTRO clinical practice guideline

Dana-Farber

December 20, 2023

Novel Artificial Intelligence Technology Shows Promising Results for Earlier and More Accurate Breast Cancer Detection

Data from the Centers for Disease Control and Prevention highlight that Breast Cancer is second most common form of cancer among women in the U.S. with approximately 240,000 new breast cancer diagnoses each year.

Baptist Health South Florida